BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bi X, Lv X, Liu D, Guo H, Yao G, Wang L, Liang X, Yang Y. METTL3 promotes the initiation and metastasis of ovarian cancer by inhibiting CCNG2 expression via promoting the maturation of pri-microRNA-1246. Cell Death Discov 2021;7:237. [PMID: 34497267 DOI: 10.1038/s41420-021-00600-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang L, Liang D, Zhang Y, Chen X, Chen J, Wen C, Liu H, Yang X, Yang X, Lin S. METTL3 promotes colorectal cancer metastasis by promoting the maturation of pri-microRNA-196b. J Cancer Res Clin Oncol 2022. [DOI: 10.1007/s00432-022-04429-9] [Reference Citation Analysis]
2 Cui S. METTL3 ‐mediated m6A modification of lnc RNA RHPN1‐AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K / AKT pathway. Clinical Laboratory Analysis 2022. [DOI: 10.1002/jcla.24761] [Reference Citation Analysis]
3 Li Y, He X, Lu X, Gong Z, Li Q, Zhang L, Yang R, Wu C, Huang J, Ding J, He Y, Liu W, Chen C, Cao B, Zhou D, Shi Y, Chen J, Wang C, Zhang S, Zhang J, Ye J, You H. METTL3 acetylation impedes cancer metastasis via fine-tuning its nuclear and cytosolic functions. Nat Commun 2022;13:6350. [PMID: 36289222 DOI: 10.1038/s41467-022-34209-5] [Reference Citation Analysis]
4 Fang Z, Mei W, Qu C, Lu J, Shang L, Cao F, Li F. Role of m6A writers, erasers and readers in cancer. Exp Hematol Oncol 2022;11:45. [PMID: 35945641 DOI: 10.1186/s40164-022-00298-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Jia J, Wu S, Jia Z, Wang C, Ju C, Sheng J, He F, Zhou M, He J. Novel insights into m6A modification of coding and non-coding RNAs in tumor biology: From molecular mechanisms to therapeutic significance. Int J Biol Sci 2022;18:4432-51. [PMID: 35864970 DOI: 10.7150/ijbs.73093] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Shen Z, Gu L, Liu Y, Wang L, Zhu J, Tang S, Wei X, Wang J, Zhang S, Wang X, Cheng X, Xie X, Lu W. PLAA suppresses ovarian cancer metastasis via METTL3-mediated m6A modification of TRPC3 mRNA. Oncogene. [DOI: 10.1038/s41388-022-02411-w] [Reference Citation Analysis]
7 Zhang C, Liu N. N6-methyladenosine (m6A) modification in gynecological malignancies. J Cell Physiol 2022. [PMID: 35802474 DOI: 10.1002/jcp.30828] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Qu X, Zhang Y, Sang X, Ren D, Zhao H, Wong STC. Methyladenosine Modification in RNAs: From Regulatory Roles to Therapeutic Implications in Cancer. Cancers 2022;14:3195. [DOI: 10.3390/cancers14133195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mao Y, Li W, Weng Y, Hua B, Gu X, Lu C, Xu B, Xu H, Wang Z. METTL3-Mediated m6A Modification of lncRNA MALAT1 Facilitates Prostate Cancer Growth by Activation of PI3K/AKT Signaling. Cell Transplant 2022;31:9636897221122997. [PMID: 36073002 DOI: 10.1177/09636897221122997] [Reference Citation Analysis]